Session activity on Clovis Oncology, Inc.(NASDAQ:CLVS) stock is placing it on today’s most active list. After a recent spot-check, the stock has touched $90.76 which represents a change from the open of 2.77%.
Company shares have been seen trading -0.26% off of the 52 week high and 684.44% away from the 52 week low. Narrowing in, the stock is at a distance of -0.26% from the 50 day high and 99.82% off of the 50 day low.Covering sell-side analysts have recently weighed in on shares of Clovis Oncology, Inc. (NASDAQ:CLVS). At the time of writing, the First Call consensus price target for the company is $70.00. The current consensus recommendation provided by covering analysts is 2.20. This recommendation lands on a scale between 1 and 5. Analysts giving shares a rating of 1 or 2 would be indicating a Buy. A rating of 4 or 5 would represent a Sell recommendation. Analysts pegging the company with a rating of 3 would be indicating a Hold recommendation.
Since the beginning of the calendar year, the stock is 97.84%. For the quarter, shares have been noted at 25.45%. Share performance for the month is currently at 60.86%. Tightening the gaze, stock performance for the last 5 trading days is 46.25%.